跳至主要内容
临床试验/PACTR201706002304422
PACTR201706002304422已完成未知

Efficacy of tranexamic acid at reducing blood loss during elective caesarean section in Abakaliki: a randomized double blind placebo controlled trial

federal teaching hospital abakaliki0 个研究点目标入组 120 人开始时间: 2017年5月20日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Year(s) 至 45 Year(s)(—)
性别
Female

入选标准

  • 1. Parturients with singleton pregnancy at 37-42 weeks¿ gestational age
  • 2. Patient on admission for elective caesarean section
  • 3. patients without contraindication to tranexamic acid
  • 4. patient who have signed the informed consent

排除标准

  • 1. Women who have known allergy to tranexamic acid
  • 2. Women with prior history of thromboembolism
  • 3. Women with bleeding disorders
  • 4. Patients with renal disease
  • 5. Patients with liver pathology
  • 6. Patients with chronic hypertension
  • 7. Patients with preeclampsia/eclampsia
  • 8. Women with antepartum haemorrhage
  • 9. Patients with varicose veins at increased risk of deep vein thrombosis
  • 10. Patients who do not consent to the study.

研究者

发起方
federal teaching hospital abakaliki

相似试验